These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30904392)

  • 1. Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.
    Baffi TR; Van AN; Zhao W; Mills GB; Newton AC
    Mol Cell; 2019 Apr; 74(2):378-392.e5. PubMed ID: 30904392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphatase PHLPP controls the cellular levels of protein kinase C.
    Gao T; Brognard J; Newton AC
    J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).
    Crotty TM; Nakano T; Stafforini DM; Topham MK
    J Biol Chem; 2013 Jan; 288(3):1439-47. PubMed ID: 23184957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
    Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
    Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).
    Gangula NR; Maddika S
    J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHLiPPing the switch on Akt and protein kinase C signaling.
    Brognard J; Newton AC
    Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation.
    Bradley EW; Carpio LR; Newton AC; Westendorf JJ
    J Biol Chem; 2015 Jun; 290(26):16272-80. PubMed ID: 25953896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus.
    Jackson TC; Verrier JD; Semple-Rowland S; Kumar A; Foster TC
    J Neurochem; 2010 Nov; 115(4):941-55. PubMed ID: 20819118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
    Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHLPPing the balance: restoration of protein kinase C in cancer.
    Tovell H; Newton AC
    Biochem J; 2021 Jan; 478(2):341-355. PubMed ID: 33502516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells.
    Suljagic M; Laurenti L; Tarnani M; Alam M; Malek SN; Efremov DG
    Leukemia; 2010 Dec; 24(12):2063-71. PubMed ID: 20861921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and consequences of the loss of PHLPP1 phosphatase in chronic lymphocytic leukemia (CLL).
    O'Hayre M; Niederst M; Fecteau JF; Nguyen VM; Kipps TJ; Messmer D; Newton AC; Handel TM
    Leukemia; 2012 Jul; 26(7):1689-92. PubMed ID: 22237780
    [No Abstract]   [Full Text] [Related]  

  • 16. PHLPP Signaling in Immune Cells.
    Lordén G; Lam AJ; Levings MK; Newton AC
    Curr Top Microbiol Immunol; 2022; 436():117-143. PubMed ID: 36243842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C fusion proteins are paradoxically loss of function in cancer.
    Van AN; Kunkel MT; Baffi TR; Lordén G; Antal CE; Banerjee S; Newton AC
    J Biol Chem; 2021; 296():100445. PubMed ID: 33617877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
    Huang YS; Chang CC; Lee SS; Jou YS; Shih HM
    Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
    Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic suppression of PHLPP1 in human melanoma.
    Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST
    Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.